Elixinol Wellness(ASX) EXL

Elixinol Wellness Limited is an international company based in Sydney, Australia, specializing in the manufacturing and distribution of hemp-derived products. Established in 2017, the company offers a diverse range of products, including nutraceuticals, cosmetics, and food items, marketed under the Elixinol and Hemp Foods Australia brands.

Products and Services

• Hemp-derived cannabidiol (CBD) products
• Nutraceuticals and dietary supplements
• Topical skincare solutions

Growth Outlook

• Revenue increased to AUD 7.86 million in Q4 2025
• Gross profit margin improved to 5.7% in Q4 2025
• Expansion into new markets across the Americas and Europe

Financial Highlights

• Trailing twelve months (TTM) revenue of AUD 30.5 million
• Net income of AUD -2.41 million in Q4 2025
• Current ratio of 0.86 indicates liquidity challenges

Elixinol Wellness Limited operates in the healthcare sector, focusing on the growing demand for hemp-derived products. The company has shown a notable increase in revenue, reaching AUD 7.86 million in the most recent quarter, reflecting a positive trend in consumer interest. Despite facing challenges, such as a net income loss of AUD 2.41 million, the company is actively working to improve its financial performance. The gross profit margin has seen a slight recovery, indicating potential for better profitability in the future. The current ratio of 0.86 suggests that while there are liquidity concerns, the company is managing its short-term obligations. With ongoing expansion efforts into new markets, Elixinol Wellness Limited is positioned to capitalize on the increasing global demand for hemp-derived products, making it a noteworthy entity in the specialty drug manufacturing industry.